摘要
目的观察格列美脲与阿卡波糖治疗2型糖尿病(T2DM)的临床疗效。方法选取T2DM患者60例，予以格列美脲与阿卡波糖口服12周。结果治疗后TG(甘油三酯)、TC(总胆固醇)、LDL-C(低密度脂蛋白)、FPG(空腹血糖)、2hPG(餐后2h血糖)、HbA1c(糖化血红蛋白)均下降(P <0.05)，HDL-C(高密度脂蛋白)升高(P <0.05)，HOMA-IR(胰岛素抵抗指数)改善(P <0.05)。结论格列美脲联合阿卡波糖治疗T2DM，血糖控制满意，血脂、HOMA-IR改善。
Abstract
Objective To observe glimepiride and acarbose treatment on 60 cases with type 2 diabetes mellitus(T2DM). Method Glimepiride and acarbose were used 12 weeks in 60 patients with T2DM. Results TG,TC, LDL-C, FBG, 2hPG and HbA1c decreased while HDL-C incressed after treatment(P <0.05); HOMA-IR was improved more significantly(P <0.05). Conclusion Glimepiride and acarbose to treat T2DM have satisfactory effects in glucose, blood lipids and HOMA-IR.
NETL
NSTL
维普
万方数据